# Changchun Zhuoyi Biological Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/changchun-zhuoyi-biological-co

- Industry: Biotechnology
- Headquarters: Changchun, China
- Website: www.zy-bio.cn
- Latest round: Angel (Mar 1, 2010)
- Investors on record: 1

## About

Established in 2005 and based in Changchun, China, Changchun Zhuoyi Biological Co., Ltd. is a biopharmaceutical company specializing in the development of vaccine biological products. The company's CEO, Feng Xingfu, has been involved in the biopharmaceutical industry since the 1980s, bringing a wealth of experience to the company. With a focus on innovation, the company has developed a range of products and is actively pursuing clinical trials for several new vaccine candidates. In June 2020,  the company closed a round of strategic investment.

The company provides a variety of biopharmaceutical products, including the freeze-dried human rabies vaccine (Vero cell). The company's product line also includes vaccines for hand, foot, and mouth disease, cervical cancer, and rotavirus in the pipeline. The company's products are designed to cater to the healthcare industry, focusing on disease prevention and treatment.

The company generates revenue by selling its biopharmaceutical products, primarily vaccines, to the healthcare market.

## Funding rounds

- Angel, Mar 1, 2010 — Ch-Gemstone Capital

## Investors

- Ch-Gemstone Capital — Angel